Parkinson’s infusion treatment demonstrates advantage over oral delivery
European Pharmaceutical Review
MARCH 18, 2024
A Phase III trial has shown that compared oral drug delivery, administering levodopa through an infusion pump led to nearly two hours of day (1.72) of additional time in which the medicine reduced symptoms in Parkinson’s patients. The research paper comparing the two drug delivery methods was published in The Lancet Neurology.
Let's personalize your content